Works matching IS 00071048 AND DT 2012 AND VI 157 AND IP 2

Results: 23

Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 249, doi. 10.1111/j.1365-2141.2011.08937.x

By:

Vasavda, Nisha;
Woodley, Claire;
Allman, Marlene;
Drašar, Emma;
Awogbade, Moji;
Howard, Jo;
Thein, Swee L.

Publication type:

Article

Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 220, doi. 10.1111/j.1365-2141.2012.09034.x

By:

Ringdén, Olle;
Labopin, Myriam;
Gorin, Norbert-Claude;
Volin, Liisa;
Torelli, Giovanni F.;
Attal, Michel;
Jouet, Jean P.;
Milpied, Noel;
Socié, Gerard;
Cordonnier, Catherine;
Michallet, Mauricette;
Atienza, Arturo I.;
Hermine, Olivier;
Mohty, Mohamad

Publication type:

Article

Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 256, doi. 10.1111/j.1365-2141.2011.08950.x

By:

Tagariello, Giuseppe;
Sartori, Roberto;
Radossi, Paolo;
Maschio, Nilla;
Risato, Renzo;
Stasi, Roberto

Publication type:

Article

De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 266, doi. 10.1111/j.1365-2141.2011.08972.x

By:

Portell, Craig A.;
Sekeres, Mikkael A.;
Rogers, Heesun J.;
Tiu, Ramon V.

Publication type:

Article

Eltrombopag named patient programme for patients with chronic immune thrombocytopenia.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 259, doi. 10.1111/j.1365-2141.2011.08954.x

By:

Scully, Maria;
Kaczmarski, Richard;
Myers, Bethan;
Collins, Rod;
Emohare, Osa;
Bolton-Maggs, Paula H. B.

Publication type:

Article

Treatment of the elderly patient with diffuse large B cell lymphoma.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 159, doi. 10.1111/j.1365-2141.2011.09011.x

By:

Fields, Paul A.;
Linch, David C.

Publication type:

Article

Acute myeloid leukaemia with inv(3)(q21q26).

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 158, doi. 10.1111/j.1365-2141.2012.09062.x

By:

Wong, K.F.;
Wong, Kris H.F.

Publication type:

Article

Human erythrocyte remodelling during Plasmodium falciparum malaria parasite growth and egress.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 171, doi. 10.1111/j.1365-2141.2012.09044.x

By:

Mbengue, Alassane;
Yam, Xue Y.;
Braun-Breton, Catherine

Publication type:

Article

T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 205, doi. 10.1111/j.1365-2141.2012.09048.x

By:

Geyer, Mark B.;
Ricci, Angela M.;
Jacobson, Judith S.;
Majzner, Robbie;
Duffy, Deirdre;
Ven, Carmella;
Ayello, Janet;
Bhatia, Monica;
Garvin, James H.;
George, Diane;
Satwani, Prakash;
Harrison, Lauren;
Morris, Erin;
Semidei-Pomales, Mildred;
Schwartz, Joseph;
Alobeid, Bachir;
Baxter-Lowe, Lee Ann;
Cairo, Mitchell S.

Publication type:

Article

Improved outcome of allogeneic haemopoietic stem cell transplantation for children with philadelphia positive acute lymphoblastic leukaemia.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 261, doi. 10.1111/j.1365-2141.2011.08953.x

By:

Garg, Anshu;
Sankar, Adhithya;
Williams, Janet;
Astwood, Emma;
Payne, Jeanette;
Welch, Jenny;
Rush, Shan;
Marples, Julie;
Barrott, Sharon;
Vora, Ajay

Publication type:

Article

Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 201, doi. 10.1111/j.1365-2141.2011.08993.x

By:

Greaves, Paul;
Wilson, Andrew;
Matthews, Janet;
Brown, Daniel L. P.;
Auer, Rebecca;
Montoto, Silvia;
Lister, T. Andrew;
Gribben, John G

Publication type:

Article

Transcriptional regulation of MIR29B by PU.1 ( SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 270, doi. 10.1111/j.1365-2141.2011.08964.x

By:

Batliner, Jasmin;
Buehrer, Emanuel;
Federzoni, Elena A.;
Jenal, Mathias;
Tobler, Andreas;
Torbett, Bruce E.;
Fey, Martin F.;
Tschan, Mario P.

Publication type:

Article

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 240, doi. 10.1111/j.1365-2141.2012.09061.x

By:

Flanagan, Jonathan M.;
Steward, Shirley;
Howard, Thad A.;
Mortier, Nicole A.;
Kimble, Amy C.;
Aygun, Banu;
Hankins, Jane S.;
Neale, Geoffrey A.;
Ware, Russell E.

Publication type:

Article

An acquired CSF3R mutation in an adult chronic idiopathic neutropenia patient who developed acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 264, doi. 10.1111/j.1365-2141.2011.08968.x

By:

Ikewaki, Junji;
Kawano, Rie;
Sato, Takako;
Imamura, Tomoyuki;
Kohno, Kazuhiro;
Ogata, Masao;
Ohtsuka, Eiichi;
Kadota, Jun-Ichi

Publication type:

Article

Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 254, doi. 10.1111/j.1365-2141.2011.08939.x

By:

Ohyashiki, Kazuma;
Katagiri, Sei-ichiro;
Tauchi, Tetsuzo;
Ohyashiki, Junko H;
Maeda, Yasuhiro;
Matsumura, Itaru;
Kyo, Tai-ichi

Publication type:

Article

Incidence, risk factors and outcome of histological transformation in follicular lymphoma.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 188, doi. 10.1111/j.1365-2141.2012.09054.x

By:

Conconi, Annarita;
Ponzio, Carlotta;
Lobetti-Bodoni, Chiara;
Motta, Maddalena;
Rancoita, Paola M.V.;
Stathis, Anastasios;
Moccia, Alden A.;
Mazzucchelli, Luca;
Bertoni, Francesco;
Ghielmini, Michele;
Cavalli, Franco;
Zucca, Emanuele

Publication type:

Article

Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 230, doi. 10.1111/j.1365-2141.2011.09025.x

By:

Oudot-Mellakh, Tiphaine;
Cohen, William;
Germain, Marine;
Saut, Noémie;
Kallel, Choumous;
Zelenika, Diana;
Lathrop, Mark;
Trégouët, David-Alexandre;
Morange, Pierre-Emmanuel

Publication type:

Article

Pyrosequencing of BRAF V600E in routine samples of Hairy Cell Leukaemia identifies CD5+ variant Hairy Cell Leukaemia that lacks V600E.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 267, doi. 10.1111/j.1365-2141.2011.08963.x

By:

Lennerz, Jochen K.;
Klaus, Beate M.;
Marienfeld, Ralf B.;
Möller, Peter

Publication type:

Article

Amplified segment in the 'Down Syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 197, doi. 10.1111/j.1365-2141.2011.08985.x

By:

Canzonetta, Claudia;
Hoischen, Alexander;
Giarin, Emanuela;
Basso, Guiseppe;
Veltman, Joris A.;
Nacheva, Elisabeth;
Nizetic, Dean;
Groet, Jürgen

Publication type:

Article

Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 252, doi. 10.1111/j.1365-2141.2011.08938.x

By:

Taoka, Kazuki;
Yamamoto, Go;
Kaburaki, Toshikatsu;
Takahashi, Tsuyoshi;
Araie, Makoto;
Kurokawa, Mineo

Publication type:

Article

Perinephric extramedullary haematopoiesis in primary myelofibrosis.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 157, doi. 10.1111/j.1365-2141.2012.09053.x

By:

Baumann Kreuziger, Lisa;
Carlson, Michelle;
Mesa, Hector;
Gupta, Pankaj

Publication type:

Article

The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 274, doi. 10.1111/j.1365-2141.2011.08989.x

By:

Berger, Juliette;
Stirnemann, Jérôme;
Bourgne, Céline;
Pereira, Bruno;
Pigeon, Pascale;
Heraoui, Djazia;
Froissart, Roseline;
Rapatel, Chantal;
Rose, Christian;
Belmatoug, Nadia;
Berger, Marc G.

Publication type:

Article

A 15q24 microdeletion in transient myeloproliferative disease ( TMD) and acute megakaryoblastic leukaemia ( AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/ AMKL.

Published in:

British Journal of Haematology, 2012, v. 157, n. 2, p. 180, doi. 10.1111/j.1365-2141.2012.09028.x

By:

Haemmerling, Susanne;
Behnisch, Wolfgang;
Doerks, Tobias;
Korbel, Jan O.;
Bork, Peer;
Moog, Ute;
Hentze, Sabine;
Grasshoff, Ute;
Bonin, Michael;
Rieß, Olaf;
Janssen, Johannes W. G.;
Jauch, Anna;
Bartram, Claus R.;
Reinhardt, Dirk;
Koch, Karin A.;
Bandapalli, Obul R.;
Kulozik, Andreas E.

Publication type:

Article

Works matching IS 00071048 AND DT 2012 AND VI 157 AND IP 2

Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.

Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.

Romiplostim for the early management of severe immune thrombocytopenia unresponsive to conventional treatment.

De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

Eltrombopag named patient programme for patients with chronic immune thrombocytopenia.

Treatment of the elderly patient with diffuse large B cell lymphoma.

Acute myeloid leukaemia with inv(3)(q21q26).

Human erythrocyte remodelling during Plasmodium falciparum malaria parasite growth and egress.

T cell depletion utilizing CD34<sup>+</sup> stem cell selection and CD3<sup>+</sup> addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients.

Improved outcome of allogeneic haemopoietic stem cell transplantation for children with philadelphia positive acute lymphoblastic leukaemia.

Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.

Transcriptional regulation of MIR29B by PU.1 ( SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells.

Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.

An acquired CSF3R mutation in an adult chronic idiopathic neutropenia patient who developed acute myeloid leukaemia.

Increased natural killer cells and decreased CD3<sup>+</sup>CD8<sup>+</sup>CD62L<sup>+</sup> T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.

Incidence, risk factors and outcome of histological transformation in follicular lymphoma.

Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.

Pyrosequencing of BRAF V600E in routine samples of Hairy Cell Leukaemia identifies CD5+ variant Hairy Cell Leukaemia that lacks V600E.

Amplified segment in the 'Down Syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2.

Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.

Perinephric extramedullary haematopoiesis in primary myelofibrosis.

The uptake of recombinant glucocerebrosidases by blood monocytes from type 1 Gaucher disease patients is variable.

A 15q24 microdeletion in transient myeloproliferative disease ( TMD) and acute megakaryoblastic leukaemia ( AMKL) implicates PML and SUMO3 in the leukaemogenesis of TMD/ AMKL.